Safety and efficacy of danaparoid (Orgaran) use in children.
about
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Pharmacokinetics, efficacy, and safety of LMWHs in venous thrombosis and stroke in neonates, infants and childrenGuideline on the investigation, management and prevention of venous thrombosis in children.
P2860
Safety and efficacy of danaparoid (Orgaran) use in children.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Safety and efficacy of danaparoid (Orgaran) use in children.
@ast
Safety and efficacy of danaparoid (Orgaran) use in children.
@en
type
label
Safety and efficacy of danaparoid (Orgaran) use in children.
@ast
Safety and efficacy of danaparoid (Orgaran) use in children.
@en
prefLabel
Safety and efficacy of danaparoid (Orgaran) use in children.
@ast
Safety and efficacy of danaparoid (Orgaran) use in children.
@en
P2093
P2860
P356
P1433
P1476
Safety and efficacy of danaparoid (Orgaran) use in children.
@en
P2093
Harry N Magnani
Karin Kurnik
Monika Girisch
P2860
P304
P356
10.1159/000090941
P577
2006-01-01T00:00:00Z